US-guided Hydro Dissection vs Fluoroscopy-guided Hydro Dissection for Adhesive Capsulitis
Launched by DISKAPI TEACHING AND RESEARCH HOSPITAL · Mar 17, 2025
Trial Information
Current as of April 30, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the best way to treat shoulder pain caused by a condition known as adhesive capsulitis, commonly referred to as frozen shoulder. The study compares two methods of guiding a treatment called hydrodilatation therapy—one using ultrasound (a type of imaging that uses sound waves) and the other using fluoroscopy (a type of X-ray). The goal is to find out which method helps improve shoulder movement, reduces pain, and enhances overall shoulder function better.
To participate in this trial, individuals must be between the ages of 65 and 74 and have been diagnosed with frozen shoulder, experiencing significant pain (rated above 5 on a scale from 1 to 10). However, people with other shoulder problems, allergies to local anesthetics, or certain medical conditions that could affect their treatment are not eligible. Participants can expect to receive the hydrodilatation therapy with either ultrasound or fluoroscopy guidance, along with a nerve block to help manage pain. This study is currently recruiting, and your involvement could help improve treatment options for frozen shoulder in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of frozen shoulder disease
- • VAS\>5
- Exclusion Criteria:
- • Other shoulder diseases that may cause shoulder pain (Rotator cuff tear, clavicle fracture, etc.)
- • Allergy to local anesthetics
- • History of shoulder surgery in the last 12 months
- • Pregnancy
- • Coagulopathy or antiplatelet use
- • The patient has a mental illness that prevents decision-making
About Diskapi Teaching And Research Hospital
Diskapi Teaching and Research Hospital is a prominent medical institution dedicated to advancing healthcare through innovative clinical research and education. As a leading sponsor of clinical trials, the hospital is committed to enhancing patient outcomes and contributing to medical knowledge across various disciplines. With a focus on rigorous scientific protocols and ethical standards, Diskapi leverages its state-of-the-art facilities and a multidisciplinary team of experts to conduct trials that explore new therapeutic options and improve existing treatments. Through collaboration with healthcare professionals and researchers, Diskapi aims to translate research findings into practical applications that benefit patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Gevher Rabia Genc Perdecioğlu
Study Chair
Diskapi TRH
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported